EV/EBITDA:
-8.47+0.15(+1.74%)Summary
- As of today (September 16, 2025), AKRO EV/EBITDA is -8.47, with a rise of +0.15 (+1.74%) during the most recent trading session on September 15, 2025.
- Over the past year, AKRO EV/EBITDA has dropped by -3.46 (-69.06%).
- AKRO EV/EBITDA is now -1000.00% below its all-time high of -0.77.
Performance
AKRO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AKRO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.7% | -1.8% | -1.4% |
| 1 m1 month | +16.1% | -16.1% | -13.2% |
| 3 m3 months | +31.4% | -28.1% | -23.0% |
| 6 m6 months | +13.9% | -3.1% | -2.9% |
| ytdytd | -84.9% | +108.3% | +54.0% |
| 1 y1 year | -69.1% | +131.8% | +56.7% |
| 5 y5 years | +55.0% | +136.3% | +18.5% |
AKRO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -8.47 | at high | -10.09 | +16.1% |
| 3 m | 3-month | -8.47 | at high | -12.52 | +32.4% |
| 6 m | 6-month | -6.73 | -25.9% | -12.52 | +32.4% |
| 1 y | 1-year | -3.07 | -175.9% | -12.90 | +34.3% |
| 3 y | 3-year | -0.77 | -1000.0% | -24.06 | +64.8% |
| 5 y | 5-year | -0.77 | -1000.0% | -24.06 | +64.8% |
| alltime | all time | -0.77 | -1000.0% | -38.76 | +78.2% |
AKRO EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -8.47(+84.9%) |
| 2024 | -4.58(+1.8%) |
| 2023 | -4.50(-76.8%) |
| Date | Value |
|---|---|
| 2022 | -19.39(+253.8%) |
| 2021 | -5.48(-30.5%) |
| 2020 | -7.88(-27.8%) |
| 2019 | -10.91 |
FAQ
- What is Akero Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Akero Therapeutics, Inc.?
- What is AKRO EV/EBITDA year-to-date change?
- What is Akero Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Akero Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of AKRO is -8.47
What is the all time high EV/EBITDA for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high EV/EBITDA is -0.77
What is AKRO EV/EBITDA year-to-date change?
Akero Therapeutics, Inc. EV/EBITDA has changed by -3.89 (-84.93%) since the beginning of the year
What is Akero Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, AKRO EV/EBITDA has changed by -3.46 (-69.06%)